Galvin, Gaustad & Stein, LLC Eli Lilly & CO Transaction History

Galvin, Gaustad & Stein, LLC

$1.06 Billion
Q4 2024

A detailed history of Galvin, Gaustad & Stein, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Galvin, Gaustad & Stein, LLC holds 1,768 shares of LLY stock, worth $1.49 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,768

Previous 1,821 2.91%

Holding current value

$1.49 Million

Previous $1.61 Million 15.44%

% of portfolio

0.13%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$727.2 - $932.06 $38,541 - $49,399	-53 Reduced 2.91%	1,768 $1.36 Million
Q3 2024 Nov 01, 2024	SELL	$772.14 - $960.02 $102,694 - $127,682	-133 Reduced 6.81%	1,821 $1.61 Million
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $52,915 - $66,359	-73 Reduced 3.6%	1,954 $1.77 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $286,032 - $382,671	-483 Reduced 19.24%	2,027 $1.58 Million
Q4 2023 Jan 11, 2024	SELL	$525.19 - $619.13 $55,144 - $65,008	-105 Reduced 4.02%	2,510 $1.46 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $31,298 - $43,149	-72 Reduced 2.68%	2,615 $1.4 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $25,954 - $34,704	-74 Reduced 2.68%	2,687 $1.26 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $290,749 - $341,471	-936 Reduced 25.32%	2,761 $948,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $283,607 - $330,458	-882 Reduced 19.26%	3,697 $1.35 Million
Q3 2022 Oct 26, 2022	SELL	$296.48 - $337.87 $28,758 - $32,773	-97 Reduced 2.07%	4,579 $1.48 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $207,932 - $244,143	-746 Reduced 13.76%	4,676 $1.52 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $108,896 - $135,330	-464 Reduced 7.88%	5,422 $1.55 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $20,011 - $24,834	89 Added 1.54%	5,886 $1.63 Million
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $360,764 - $443,971	-1,628 Reduced 21.93%	5,797 $1.34 Million
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $68,789 - $88,978	-381 Reduced 4.88%	7,425 $1.7 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $86,103 - $111,465	-524 Reduced 6.29%	7,806 $1.46 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $1.09 Million - $1.44 Million	8,330 New	8,330 $1.41 Million

Others Institutions Holding LLY

# of Institutions

4,091

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $800B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.

Account

Galvin, Gaustad & Stein, LLC Eli Lilly & CO Transaction History